Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06522334
NCT06522334
Recruiting
Not Applicable

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Ludwig Boltzmann Institute for Lung Health5 sites in 1 country400 target enrollmentFebruary 28, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInterstitial Lung Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interstitial Lung Disease
Sponsor
Ludwig Boltzmann Institute for Lung Health
Enrollment
400
Locations
5
Primary Endpoint
Mortality
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death.

There are no additional interventions regarding this registry.

Registry
clinicaltrials.gov
Start Date
February 28, 2024
End Date
February 28, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ludwig Boltzmann Institute for Lung Health
Responsible Party
Principal Investigator
Principal Investigator

Robab Breyer-Kohansal

Head of Department for Internal Medicine and Pneumology Clinic Hietzing

Ludwig Boltzmann Institute for Lung Health

Eligibility Criteria

Inclusion Criteria

  • •diagnosis of interstitial lung disease
  • •written informed consent

Exclusion Criteria

  • •to not comprehend and rightfully judge participation

Outcomes

Primary Outcomes

Mortality

Time Frame: 10 years

Mortality caused by interstitial lung disease

Loss of lung function

Time Frame: 2 years

FVC and DLCO loss within 24 months

Secondary Outcomes

  • Prevalence(10 years)
  • Response to drugs(10 years)

Study Sites (5)

Loading locations...

Similar Trials

Unknown
Not Applicable
Interstitial Lung Disease Registry ConstructionInterstitial Lung Disease
NCT03238989Seoul National University Hospital300
Completed
Not Applicable
Idiopathic Pulmonary Fibrosis Registry for Future StudiesLung Disease, InterstitialIdiopathic Pulmonary Fibrosis
NCT00815711Ohio State University13
Recruiting
Not Applicable
Interstitial Lung Disease Research Unit BiobankInterstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary FibrosisPulmonary FibrosisHypersensitivity Pneumonitis
NCT05392881University of Kansas Medical Center1,000
Unknown
Not Applicable
Pulmonary Care and Research Collaborative Patient RegistryInterstitial Lung Disease
NCT05445817Pulmonary Care and Research Collaborative Limited150
Recruiting
Not Applicable
Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPDChronic Obstructive Pulmonary DiseaseAsthma
NCT05826613Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico500